“I’d like to underscore the significance of adopting multifaceted approaches in the study and management of hyperkinetic movement disorders. These approaches should encompass not only motor symptoms ...
A 59-year-old woman with a background of HIV living with an uncontrollable movement disorder presented to Eoghan Donlon, MB, BCh BAO, MRCPI, of the Mater Misericordiae University Hospital in Dublin, ...
GlobalData on MSN
Neurocrine Biosciences begins phase II NBI-1065890 trial for TD
The double-blind, placebo-controlled Phase II trial is enrolling approximately 100 adult participants with tardive dyskinesia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results